These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21091098)

  • 41. Cost of fractures commonly associated with osteoporosis in a managed-care population.
    Christensen L; Iqbal S; Macarios D; Badamgarav E; Harley C
    J Med Econ; 2010; 13(2):302-13. PubMed ID: 20482324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beyond the myths: finding benefit design solutions that address the true costs of high healthcare use.
    Willey VJ; Kopenski F; Lawless GD
    Am J Manag Care; 2008 Jul; 14(8 Suppl):S252-63. PubMed ID: 18672956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct and indirect costs attributable to osteoarthritis in active subjects.
    Rabenda V; Manette C; Lemmens R; Mariani AM; Struvay N; Reginster JY
    J Rheumatol; 2006 Jun; 33(6):1152-8. PubMed ID: 16755664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of chronic type B and C hepatitis with interferon alfa: an economic appraisal.
    Dusheiko GM; Roberts JA
    Hepatology; 1995 Dec; 22(6):1863-73. PubMed ID: 7489999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors associated with the initiation of alpha-interferon treatment in Medicaid patients diagnosed with hepatitis C.
    Markowitz JS; Gutterman EM; Hodes D; Klaskala W
    J Viral Hepat; 2005 Mar; 12(2):176-85. PubMed ID: 15720533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health-related quality of life in patients seeking gastric bypass surgery vs non-treatment-seeking controls.
    Kolotkin RL; Crosby RD; Pendleton R; Strong M; Gress RE; Adams T
    Obes Surg; 2003 Jun; 13(3):371-7. PubMed ID: 12841896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infection.
    Deterding K; Wiegand J; Grüner N; Hahn A; Jäckel E; Jung MC; Buggisch P; Galle P; Berg T; Hinrichsen H; Potthoff A; Zeuzem S; Cornberg M; Manns M; Wedemeyer H
    Z Gastroenterol; 2009 Jun; 47(6):531-40. PubMed ID: 19533544
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Burden of schizophrenia in recently diagnosed patients: healthcare utilisation and cost perspective.
    Nicholl D; Akhras KS; Diels J; Schadrack J
    Curr Med Res Opin; 2010 Apr; 26(4):943-55. PubMed ID: 20163295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C.
    Fontana RJ; Moyer CA; Sonnad S; Lok ASF ; Sneed-Pee N; Walsh J; Klein S; Webster S
    Am J Gastroenterol; 2001 Jan; 96(1):170-8. PubMed ID: 11197249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.
    Lopez-Bastida J; Serrano-Aguilar P; Perestelo-Perez L; Oliva-Moreno J
    Neurology; 2006 Dec; 67(12):2186-91. PubMed ID: 17190942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medical care costs one year after identification of hyperglycemia below the threshold for diabetes.
    Nichols GA; Arondekar B; Herman WH
    Med Care; 2008 Mar; 46(3):287-92. PubMed ID: 18388843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Economic cost associated with type II diabetes in Spanish patients.
    Ballesta M; Carral F; Olveira G; Girón JA; Aguilar M
    Eur J Health Econ; 2006 Dec; 7(4):270-5. PubMed ID: 16850331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities.
    DiBonaventura Md; Wagner JS; Yuan Y; L'Italien G; Langley P; Ray Kim W
    J Med Econ; 2011; 14(2):253-61. PubMed ID: 21385147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resource utilization and healthcare costs for acute coronary syndrome patients with and without diabetes mellitus.
    Zhao Z; Zhu B; Anderson J; Fu H; LeNarz L
    J Med Econ; 2010; 13(4):748-59. PubMed ID: 21091396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The burden of untreated hepatitis C virus infection: a US patients' perspective.
    El Khoury AC; Vietri J; Prajapati G
    Dig Dis Sci; 2012 Nov; 57(11):2995-3003. PubMed ID: 22674399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Respira project: Humanistic and economic burden of asthma in Brazil.
    Cançado JED; Penha M; Gupta S; Li VW; Julian GS; Moreira ES
    J Asthma; 2019 Mar; 56(3):244-251. PubMed ID: 29595345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies.
    Estes C; Abdel-Kareem M; Abdel-Razek W; Abdel-Sameea E; Abuzeid M; Gomaa A; Osman W; Razavi H; Zaghla H; Waked I
    Aliment Pharmacol Ther; 2015 Sep; 42(6):696-706. PubMed ID: 26202593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Presence of hepatitis C (HCV) infection in Baby Boomers with Medicare is independently associated with mortality and resource utilisation.
    Sayiner M; Wymer M; Golabi P; Ford J; Srishord I; Younossi ZM
    Aliment Pharmacol Ther; 2016 May; 43(10):1060-8. PubMed ID: 26991652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predicting the Cost of Health Care Services: A Comparison of Case-mix Systems and Comorbidity Indices That Use Administrative Data.
    Huang X; Peterson S; Lavergne R; Ahuja M; McGrail K
    Med Care; 2020 Feb; 58(2):114-119. PubMed ID: 31688565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The economics associated with persistent pain.
    Phillips CJ; Harper C
    Curr Opin Support Palliat Care; 2011 Jun; 5(2):127-30. PubMed ID: 21430542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.